7QK-23119-35673
1 vaccination
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 062 / CT
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
-
2021-07-09
Survey response — 3 months, dose 1MedDRA: Abortion spontaneous, Heavy menstrual bleeding, Menstruation irregular — Feeling: GoodFree text: Extremely heavy and irregular periods. Also I miscarried the pregnancy mentioned below.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson |
Free text
Release 9 — 3 months, dose 1
Symptoms: Extremely heavy and irregular periods. Also I miscarried the pregnancy mentioned below.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release